Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (41)

2023

  1. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors

    American Journal of Psychiatry

  2. Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes

    International journal of epidemiology, Vol. 52, Núm. 2, pp. 386-402

  3. Schizophrenia polygenic risk score in psychosis proneness

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 8, pp. 1665-1675

2022

  1. Corrigendum to “Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population” [J. Affect. Disord. 249 (2019) 199–207 (Apr 15), (2019) 249(199-207) (S0165032718329604), (10.1016/j.jad.2019.02.037))

    Journal of Affective Disorders

2021

  1. Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders

    Molecular Psychiatry, Vol. 26, Núm. 4, pp. 1286-1298

  2. Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality (Molecular Psychiatry, (2020), 25, 10, (2493-2503), 10.1038/s41380-018-0339-3)

    Molecular Psychiatry

  3. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  4. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

  5. Genetic association study of childhood aggression across raters, instruments, and age

    Translational Psychiatry, Vol. 11, Núm. 1

  6. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 186, Núm. 3, pp. 140-150

  7. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

    Nature genetics, Vol. 53, Núm. 6, pp. 817-829

  8. Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2277-2285

  9. Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder

    Nature Communications, Vol. 12, Núm. 1

  10. Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2101-2110

2020

  1. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality

    Molecular Psychiatry, Vol. 25, Núm. 10, pp. 2493-2503

  2. Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults

    Translational Psychiatry, Vol. 10, Núm. 1

  3. Shared genetic background between children and adults with attention deficit/hyperactivity disorder

    Neuropsychopharmacology, Vol. 45, Núm. 10, pp. 1617-1626

  4. Transcriptome profiling in adult attention-deficit hyperactivity disorder

    European Neuropsychopharmacology, Vol. 41, pp. 160-166

2019

  1. Associations of major depressive disorder with chronic physical conditions, obesity and medication use: Results from the PISMA-ep study

    European Psychiatry, Vol. 60, pp. 20-27

  2. Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells

    Neuropsychopharmacology, Vol. 44, Núm. 5, pp. 890-897